There was a media frenzy over Romney’s joke about not being asked to see his birth certificate, Biden’s comment about being shackeled and Obama’s misspelling of Ohio.  Should, we as Americans “Chill Out” when it comes to politics?

We record almost everything we watch on TV.  It’s usually Game shows, Storage Wars and Food Network shows.  Since it’s recorded we fast forward through all the commercials.  I’m getting pretty good at hitting the stop button at the right time, almost the same way when I put gas in the vehicle.  It makes me wonder if everyone fast forwards through commercials will the TV industry have to change the way it looks at having commercials. 

Do you record your TV programs and fast forward through commercials?

I was grilling hamburgers in my back yard when I heard a large crash.  I ran to the front of our house to see a bad car accident.  I called 911 and went to the driver of the second vehicle.  It was apparent that she had been texting and ran into the back of a van taxi.  Her phone was in texting mode and in her lap.  A nurse was on site and took over.  She removed the girl from her car and had her sit across the street.  The van taxi appeared to have little damage since the car was small and actually went under the van.  (Oh by the way my hamburgers was well done but not burnt.)  I personnally don’t want any more laws.  I think we have way too many.  I would like the insurance company to take up this issue.  If you’re in an accident and texting is involved your insurance will go up. 

Do you think there should be laws against driving and texting?

Do you support Chick-Fil-A?

I copied this from the Health Care Bill

Subtitle C—National Medical
10 Device Registry
11 SEC. 2521. NATIONAL MEDICAL DEVICE REGISTRY.
12 (a) REGISTRY.—
13 (1) IN GENERAL.—Section 519 of the Federal
14 Food, Drug, and Cosmetic Act (21 U.S.C. 360i) is
15 amended—
16 (A) by redesignating subsection (g) as sub-
17 section (h); and
18 (B) by inserting after subsection (f) the
19 following:
20 ‘‘National Medical Device Registry
21 ‘‘(g)(1) The Secretary shall establish a national med-
22 ical device registry (in this subsection referred to as the
23 ‘registry’) to facilitate analysis of postmarket safety and
24 outcomes data on each device that—
25 ‘‘(A) is or has been used in or on a patient; and
F:P11NHITRICOMMAAHCA09_001.XML
f:VHLC7140971409.140.xml (444390|2)1002
1 ‘‘(B) is—
2 ‘‘(i) a class III device; or
3 ‘‘(ii) a class II device that is implantable,
4 life-supporting, or life-sustaining.
5 ‘‘(2) In developing the registry, the Secretary shall,
6 in consultation with the Commissioner of Food and Drugs,
7 the Administrator of the Centers for Medicare & Medicaid
8 Services, the head of the Office of the National Coordi-
9 nator for Health Information Technology, and the Sec-
10 retary of Veterans Affairs, determine the best methods
11 for—
12 ‘‘(A) including in the registry, in a manner con-
13 sistent with subsection (f), appropriate information
14 to identify each device described in paragraph (1) by
15 type, model, and serial number or other unique iden-
16 tifier;
17 ‘‘(B) validating methods for analyzing patient
18 safety and outcomes data from multiple sources and
19 for linking such data with the information included
20 in the registry as described in subparagraph (A), in-
21 cluding, to the extent feasible, use of—
22 ‘‘(i) data provided to the Secretary under
23 other provisions of this chapter; and
24 ‘‘(ii) information from public and private
25 sources identified under paragraph (3);
F:P11NHITRICOMMAAHCA09_001.XML
f:VHLC7140971409.140.xml (444390|2)1003
1 ‘‘(C) integrating the activities described in this
2 subsection with—
3 ‘‘(i) activities under paragraph (3) of sec-
4 tion 505(k) (relating to active postmarket risk
5 identification);
6 ‘‘(ii) activities under paragraph (4) of sec-
7 tion 505(k) (relating to advanced analysis of
8 drug safety data); and
9 ‘‘(iii) other postmarket device surveillance
10 activities of the Secretary authorized by this
11 chapter; and
12 ‘‘(D) providing public access to the data and
13 analysis collected or developed through the registry
14 in a manner and form that protects patient privacy
15 and proprietary information and is comprehensive,
16 useful, and not misleading to patients, physicians,
17 and scientists.
18 ‘‘(3)(A) To facilitate analyses of postmarket safety
19 and patient outcomes for devices described in paragraph
20 (1), the Secretary shall, in collaboration with public, aca-
21 demic, and private entities, develop methods to—
22 ‘‘(i) obtain access to disparate sources of
23 patient safety and outcomes data, including—
24 ‘‘(I) Federal health-related electronic
25 data (such as data from the Medicare proVerDate 
F:P11NHITRICOMMAAHCA09_001.XML
f:VHLC7140971409.140.xml (444390|2)1004
1 gram under title XVIII of the Social Secu-
2 rity Act or from the health systems of the
3 Department of Veterans Affairs);
4 ‘‘(II) private sector health-related
5 electronic data (such as pharmaceutical
6 purchase data and health insurance claims
7 data); and
8 ‘‘(III) other data as the Secretary
9 deems necessary to permit postmarket as-
10 sessment of device safety and effectiveness;